AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of GBP 299.90 billion. The enterprise value is 347.35 billion.

Market Cap	299.90B
Enterprise Value	347.35B

Important Dates

The next estimated earnings date is Friday, January 30, 2026.

Earnings Date	Jan 30, 2026
Ex-Dividend Date	Oct 15, 2025

Share Statistics

Current Share Class	1.77B
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	74.02%
Float	1.76B

Valuation Ratios

The trailing PE ratio is 171.69 and the forward PE ratio is 16.52.

PE Ratio	171.69
Forward PE	16.52
PS Ratio	6.76
PB Ratio	-155.11
P/TBV Ratio	n/a
P/FCF Ratio	20.48
P/OCF Ratio	19.33
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.50, with an EV/FCF ratio of 23.72.

EV / Earnings	198.85
EV / Sales	7.76
EV / EBITDA	15.50
EV / EBIT	21.76
EV / FCF	23.72

Financial Position

The company has a current ratio of 0.72

Current Ratio	0.72
Quick Ratio	0.47
Debt / Equity	n/a
Debt / EBITDA	2.31
Debt / FCF	3.50
Interest Coverage	7.38

Financial Efficiency

Return on equity (ROE) is 137.96% and return on invested capital (ROIC) is 18.50%.

Return on Equity (ROE)	137.96%
Return on Assets (ROA)	9.59%
Return on Invested Capital (ROIC)	18.50%
Return on Capital Employed (ROCE)	22.50%
Revenue Per Employee	806,756
Profits Per Employee	31,759
Employee Count	55,000
Asset Turnover	0.43
Inventory Turnover	3.63

Taxes

Income Tax	-546.80M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.09% in the last 52 weeks. The beta is 0.35, so AbbVie's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	-17.09%
50-Day Moving Average	228.34
200-Day Moving Average	204.81
Relative Strength Index (RSI)	48.68
Average Volume (20 Days)	25,895

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.16

Income Statement

In the last 12 months, AbbVie had revenue of GBP 44.37 billion and earned 1.75 billion in profits. Earnings per share was 0.98.

Revenue	44.37B
Gross Profit	31.71B
Operating Income	15.82B
Pretax Income	1.23B
Net Income	1.75B
EBITDA	21.96B
EBIT	15.82B
Earnings Per Share (EPS)	0.98

Full Income Statement

Balance Sheet

The company has 4.22 billion in cash and 51.22 billion in debt, giving a net cash position of -47.00 billion.

Cash & Cash Equivalents	4.22B
Total Debt	51.22B
Net Cash	-47.00B
Net Cash Per Share	n/a
Equity (Book Value)	-1.93B
Book Value Per Share	-1.11
Working Capital	-8.07B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 15.52 billion and capital expenditures -874.87 million, giving a free cash flow of 14.64 billion.

Operating Cash Flow	15.52B
Capital Expenditures	-874.87M
Free Cash Flow	14.64B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 71.46%, with operating and profit margins of 35.65% and 4.00%.

Gross Margin	71.46%
Operating Margin	35.65%
Pretax Margin	2.78%
Profit Margin	4.00%
EBITDA Margin	49.49%
EBIT Margin	35.65%
FCF Margin	33.00%

Dividends & Yields

This stock pays an annual dividend of 5.03, which amounts to a dividend yield of 3.42%.

Dividend Per Share	5.03
Dividend Yield	3.42%
Dividend Growth (YoY)	3.94%
Years of Dividend Growth	10
Payout Ratio	481.49%
Buyback Yield	-0.01%
Shareholder Yield	3.41%
Earnings Yield	0.58%
FCF Yield	4.88%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.21 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.21
Piotroski F-Score	7